Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price11.68 USD
Fair value5.84Our model only; no analyst estimate to cross-check.
Ethical score70.0/100
Value readOvervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-11-06Read Markdown11.68+0.0% to today Distribution gives way to Markdown after a 6% slide in 7 days
2026-10-30Read Distribution12.48-6.4% to today ✓Accumulation gives way to Distribution
2026-10-23Read Accumulation13.08-10.7% to today Markup gives way to Accumulation first Accumulation read since August
2026-10-14Read Markup13.39-12.8% to today Markdown gives way to Markup after a 6% rise in 12 days
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Grupo México, S.A.B. de C.V. holds its Markdown at $11.68. The statistical read favours the sellers, held for 81 days.
As held on the ledger · 2026-11-05
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 81 days
Price at the screen
$11.68
Valuation
13.28 trailing · 21.15 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.05
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
10.97%
Below 33%
Interest-bearing debt is just 11.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
10.26%
Below 33%
Cash held in interest-bearing accounts and securities is 10.3% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
2.42%
Below 5%
Only 2.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Grupo México, S.A.B. de C.V. clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 11%, inside the ~33% line, and interest is about 2% of its income, under the ~5% line, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when GMBXF's ethical verdict changes
Today GMBXF passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our model only; no analyst estimate to cross-check.
Our analysis reads Overvalued vs our fair value, as of 5 Nov 2026: it trades above our $5.84 fair value estimate, strong competitive moat, 37.90% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. The price runs 100.0% above the base estimate.
Where our models see it going: fair-value estimate $5.84, with a range of $5.84 to $6.23, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Why it gives us pause
At 21.2x forward earnings, the price already runs ahead of the business. It trades 100% above our $5.84 fair value, so you would be buying at a premium, not a discount. The strong moat is real, but quality alone does not make an expensive price cheap.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Mexico and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
GMBXF trades on PNK (the company is based in Mexico). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-06Markdown · changed$11.68-6.4%Entry 17
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 34%.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 34%.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 34%.
2026-10-14Markup · changed$13.39+6.3%Entry 14
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 30% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 34%.
2026-10-02Markdown · changed$12.60-5.2%Entry 13
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 34%.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 12.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 34%.
2026-07-27Markup$11.86+0.0%Entry 11
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 34%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-26Markup$11.86+0.0%Entry 10
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 34%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-25Markup$11.86+1.7%Entry 9
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 34%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-24Markup$11.66+0.0%Entry 8
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 34%. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
